Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07582198 · ClinicalTrials.gov registry record · NA
Hearing Outcomes With the Nucleus® 8 Sound Processor and Nucleus® 7 Sound Processor in Adult Veteran and Non-veteran Cochlear Implant Recipients
A NA study, sponsored by Cochlear.
- Not yet
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT07582198 is a NA study that has not yet begun recruiting, run by Cochlear. The registered enrollment target is 26 participants.
The verdict
NCT07582198, a NA study, has not yet begun recruiting, sponsored by Cochlear.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The main purpose of this study is to understand how well a noise reduction feature called ForwardFocus works when used with two different sound processors: the Nucleus® 8 Sound Processor and the Nucleus® 7 Sound Processor, in adults with cochlear implants. The study will include two groups of adult cochlear implant recipients: veterans and non-veterans. Comparing these groups will help researchers understand how these sound processors perform in veteran populations as well as the broader adult cochlear implant community. Participants will use each sound processor and then take part in speech understanding tests in background noise. They will also complete questionnaires about their listening experiences with each processor.
Interventions
- DEVICE Nucleus 7 Sound Processor
- DEVICE Nucleus 8 Sound Processor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2026-05 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07582198
The ClinicalTrials.gov registry entry for NCT07582198 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nucleus 7 Sound Processor is the first listed.
NCT07582198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07582198 about?
NCT07582198 is a clinical study titled "Hearing Outcomes With the Nucleus® 8 Sound Processor and Nucleus® 7 Sound Processor in Adult Veteran and Non-veteran Cochlear Implant Recipients". The main purpose of this study is to understand how well a noise reduction feature called ForwardFocus works when used with two different sound processors: the Nucleus® 8 Sound Processor and the Nucleus® 7 Sound Processor, in adults with cochlear implants. The study will include two groups of adult...
What is the current status of trial NCT07582198?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2026-05. Estimated completion is 2026-09.
What interventions are being tested in trial NCT07582198?
The interventions under investigation include: Nucleus 7 Sound Processor (DEVICE), Nucleus 8 Sound Processor (DEVICE).
Who is sponsoring clinical trial NCT07582198?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.